Special Issue "Molecular Signaling of Natural Compounds in Oncology"

A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Pharmaceutical Science".

Deadline for manuscript submissions: 31 January 2022.

Special Issue Editors

Dr. Nipin Sp
E-Mail Website
Guest Editor
Department of Pathology, School of Medicine, Institute of Biomedical Science and Technology, Konkuk University, Chungju 27478, Korea
Interests: pathology; oncology; cancer research; biotechnology; molecular cancer biology; cancer Immunotherapy
Special Issues, Collections and Topics in MDPI journals
Dr. Dong Young Kang
E-Mail Website
Guest Editor
Department of Pathology, School of Medicine, Institute of Biomedical Science and Technology, Konkuk University, Chungju 27478, Korea
Interests: cancer; angiogenesis; metastasis; inflammation; animal science; microbiology; molecular signaling pathways; natural compounds; sulfur; tannin; drug development
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The submission of manuscripts is invited to the Special Issue of “Molecular Signaling of Natural Compounds in Oncology”, which will contain a selection of papers dealing with molecular signaling of bioactive natural compounds in cancer treatment. Original research reports, review articles and commentaries are welcome.

Cancer treatment using natural compounds is known to be a good therapeutic method as it lacks adverse effects when compared with commercially available anticancer drugs. There are many natural compounds well known for their anticancer activities, and the reason behind their anticancer activity is the presence of active components. However, the signaling mechanism of these active compounds is still unclear in many cancers. Here, we aim for the elucidation of signaling pathways in cancer hallmarks with natural-compound-based cancer treatment, thereby taking a primary step for natural-compound-based anticancer drug development.

This Special Issue aims to cover all aspects of bioactive natural compounds including, but not limited to, in vitro and in vivo activities, clinical effects, mechanism of action, and signaling pathway elucidation. Papers dealing with product development of active single components in natural nutraceuticals and dietary supplements or their synergistic combination treatment with commercially available anticancer drugs are also welcome.

Dr. Nipin Sp
Dr. Dong Young Kang
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • natural compounds
  • molecular signaling pathways
  • cancer hallmarks
  • cell cycle arrest and apoptosis
  • tumor angiogenesis
  • tumor metastasis
  • cancer immunotherapy
  • synergistic combination
  • dietary supplements
  • anticancer drug development

Published Papers

This special issue is now open for submission.
Back to TopTop